The stem cells international society establishes new record of 750 cases of adult stem cells patients

The International Cellular Medicine Society (ICMS) has recently achieved new milestone. ICMS has reached the target of 750 patients who have been provided stem cell treatments till now. ICMS is a nonprofit organization that is working for the safety of people. The society facilitates the education of doctors and provides an insight about the peer group. It has proved to be a critical step in the field of cell based medicine. Ricardo Rodriguez who is a director of ICMS, MD and co-chairperson of medical advisory board says that ICMS is based on the foundation of the safety of its patients.

The stem cells international society offers some of the finest practices and recognised clinics. Now ICMS has added one more chapter in its success story through increased number of patients. This way ICMS has come to establish itself as one of the premier organization. It is providing advanced treatments that are followed by the best care to each and every patient. Further, only those clinics that fulfill the minimum standards of the ICMS and are under review by board of institutional review are provided access to participate in treatment registry.

The treatment registry of ICMS is basically a completely secure and online data collection system that maintains track of the patients who have successfully operated through adult stem cells. After the treatment all the patients are surveyed either through surveys or interviews. It includes the interval of three, six and twelve months and even two, three, four, five, ten and twenty years. They are interviewed to determine the success rate and complications that might come into light during that time. However, this therapy has been found to report complication rate less than two percent and these do not show any severe cases.

The ICMS executive director, David Audley says that having such a significant record of patients successfully operated with negligible complication rate is an evidence of huge safety concern by the ICMS professionals. International Cellular Medicine Society has huge collection of data. The firm is determined to maintain the privacy of the patients and keep treatment procedures confidential. The data which has been recorded in the registry covers procedures of collection of cells and administration and even specific outcomes of this treatment. They are kept secure and can be accessed by only some selected clinics, patients and reviewers by ICMS.

All the reviewers are responsible for assessment of the registry data for the evaluation of the outcomes of audit patients and protocols. They have to follow strict norms and secret agreements that are kept confidential. ICMS does not publish the results gained from individual clinics. On the other hand, it publishes all the findings of some crucial stem cell research study or complaints. Cellular Medicine Society believes that the number of patients will further increase with the recently launched accredited program of stem cell clinic. With more and more clinics expanding their operations in stem cell technology and its treatments ICMS will expand further being one of the most trusted and self-regulating firms.